Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer

Autor: Edelman, Martin J., Dvorkin, Mikhail, Laktionov, Konstatin, Navarro, Alejandro, Juan-Vidal, Oscar, Kozlov, Vadim, Golden, Gil, Jordan, Odette, Deng, CQ, Bentsion, Dmitriy, Chouaid, Christos, Dechev, Hristo, Dowlati, Afshin, Fernández Núñez, Natalia, Ivashchuk, Olexandr, Kiladze, Ivane, Kortua, Tsira, Leighl, Natasha, Luft, Aleksandr, Makharadze, Tamta, Min, YoungJoo, Quantin, Xavier
Zdroj: In Lung Cancer April 2022 166:135-142
Databáze: ScienceDirect
Externí odkaz: